ahlam1399
08-22-2015, 05:18 PM
RPT-New tool will compare costs versus benefits of cancer treatments
LOS ANGELES, Aug 21 (Reuters) - As options for cancer patients become increasingly complicated, and expensive, the most influential source for U.S. oncology treatment guidelines will for the first time offer a tool to assess the costs versus benefits of available therapies.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4933e227/sc/28/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=_MMN6ZUABco:D5VkrGgFbBM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_MMN6ZUABco:D5VkrGgFbBM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=_MMN6ZUABco:D5VkrGgFbBM:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_MMN6ZUABco:D5VkrGgFbBM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=_MMN6ZUABco:D5VkrGgFbBM:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/_MMN6ZUABco
LOS ANGELES, Aug 21 (Reuters) - As options for cancer patients become increasingly complicated, and expensive, the most influential source for U.S. oncology treatment guidelines will for the first time offer a tool to assess the costs versus benefits of available therapies.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4933e227/sc/28/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=_MMN6ZUABco:D5VkrGgFbBM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_MMN6ZUABco:D5VkrGgFbBM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=_MMN6ZUABco:D5VkrGgFbBM:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_MMN6ZUABco:D5VkrGgFbBM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=_MMN6ZUABco:D5VkrGgFbBM:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/_MMN6ZUABco